Open original FDA record ↗Recall record
- FDA identifier
- Z-1387-2008
- Company in FDA record
- Baxter Healthcare Corp.
- FDA classification date
- Apr 4, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Due to an increase of adverse events in Baxter single and multi-dose Heparin for injection products, which used the same active pharmaceutical ingredient (API) source as the HEP LOCK products
Source facts
- Action
- A Press Release was issued on February 28, 2008. Recall notification letters , Urgent Product Recall, were sent on February 29, 2008, by overnight mail to customers/wholesalers/ distributors and dialysis center/renal home patients. Recall letters were also sent on March 7, 2008, to health care professionals
- Initiated
- 2008-02-28
- Root cause
- Nonconforming Material/Component
- Terminated
- 2020-02-18
- Distribution
- Worldwide Distribution --Worldwide: USA including Puerto Rico, and countries of Germany, Guam, America Samoa, Marshal Islands, Northern Mariana Island/Virgin Islands, and Qatar . Accounts included wholesalers, pharmacies, hospitals, and clinic/renal home patients
- Recall number
- Z-1387-2008
- Recall status
- Terminated
- CDRH record ID
- 68468
- FDA classified
- 2008-04-04
- Recall event number
- 46912